Pediatrix Medical Group, Inc. financial data

Symbol
MD on NYSE
Location
1301 Concord Terrace, Sunrise, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 171 % +20.9%
Debt-to-equity 158 % -6.75%
Return On Equity 19.8 %
Return On Assets 7.68 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.9M shares 0%
Common Stock, Shares, Outstanding 85.8M shares -0.04%
Entity Public Float 637M USD -45.8%
Common Stock, Value, Issued 858K USD -0.12%
Weighted Average Number of Shares Outstanding, Basic 84.6M shares +0.86%
Weighted Average Number of Shares Outstanding, Diluted 85.6M shares +1.29%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 239M USD +4.7%
Operating Income (Loss) 199M USD +101%
Nonoperating Income (Expense) 4.86M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 204M USD +248%
Income Tax Expense (Benefit) 42M USD +177%
Net Income (Loss) Attributable to Parent 162M USD +269%
Earnings Per Share, Basic 1 USD/shares +270%
Earnings Per Share, Diluted 1 USD/shares +265%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 340M USD +228%
Accounts Receivable, after Allowance for Credit Loss, Current 231M USD -19.4%
Other Assets, Current 10.2M USD +7.75%
Assets, Current 717M USD +35.8%
Deferred Income Tax Assets, Net 79.8M USD -33.2%
Property, Plant and Equipment, Net 38.6M USD -7.84%
Operating Lease, Right-of-Use Asset 34.1M USD -44.7%
Goodwill 1.26B USD +1.33%
Other Assets, Noncurrent 57.9M USD -26.3%
Assets 2.2B USD +5.9%
Accounts Payable, Current 38.7M USD -18.4%
Liabilities, Current 393M USD +5.22%
Long-term Debt and Lease Obligation 577M USD
Deferred Income Tax Liabilities, Net 38.3M USD +7.49%
Operating Lease, Liability, Noncurrent 27.5M USD -31.1%
Other Liabilities, Noncurrent 33.5M USD +1.49%
Liabilities 1.31B USD -2.65%
Accumulated Other Comprehensive Income (Loss), Net of Tax 446K USD
Retained Earnings (Accumulated Deficit) -117M USD +58.1%
Stockholders' Equity Attributable to Parent 891M USD +21.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 891M USD +21.6%
Liabilities and Equity 2.2B USD +5.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -117M USD +6.2%
Net Cash Provided by (Used in) Financing Activities -6.04M USD -108%
Net Cash Provided by (Used in) Investing Activities -7.46M USD +54%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 85.8M shares -0.04%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -131M USD -101%
Deferred Tax Assets, Valuation Allowance 425M USD -2.42%
Deferred Tax Assets, Gross 669M USD -2.58%
Operating Lease, Liability 44.6M USD -34.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 163M USD +240%
Lessee, Operating Lease, Liability, to be Paid 49.9M USD -34.8%
Property, Plant and Equipment, Gross 166M USD -24.1%
Operating Lease, Liability, Current 12.2M USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.2M USD -29.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.7M USD -38.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 4.4M USD +541%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.24M USD -36.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.69M USD -22.1%
Deferred Tax Assets, Operating Loss Carryforwards 47.9M USD +37.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 2.4M USD -1.92%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.36M USD -28.6%
Depreciation, Depletion and Amortization 23.1M USD -33%
Deferred Tax Assets, Net of Valuation Allowance 243M USD -2.85%
Share-based Payment Arrangement, Expense 10.1M USD +16.1%
Interest Expense 41.4M USD +0.67%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%